Insulin Pen Buyers Say Sanofi Antitrust Suit Not Overly Broad
Buyers of Sanofi-Aventis' Lantus insulin pen fought back Friday in Massachusetts federal court against the company's bid to trim their proposed antitrust class action on the grounds the buyer behind the...To view the full article, register now.
Already a subscriber? Click here to view full article